Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease

Blood

Volumn 90, Issue 12, 1997, Pages 4705-4709

  Storek, Jan ^a,b   Gooley, Ted ^a   Siadak, Muriel ^a   Bensinger, William I ^a   Maloney, David G ^a   Chauncey, Thomas R ^a   Flowers, Mary ^a   Sullivan, Keith M ^a   Witherspoon, Robert P ^a   Rowley, Scott D ^a   Hansen, John A ^a   Storb, Rainer ^a   Appelbaum, Frederick R ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOTRANSPLANTATION; ARTICLE; BONE MARROW TRANSPLANTATION; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; HUMAN; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RISK ASSESSMENT; STEM CELL TRANSPLANTATION;

EID: 0031454790     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.12.4705.4705_4705_4709     Document Type: Article

References (41)

1. Schmitz N, Dreger P, Suttorp M, Rohwedder EB, Haferlach T, Loffler H, Hunter A, Russell NH: Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor). Blood 85:1666, 1995
2. Korbling M, Przepiorka D, Huh YO, Engel H, Vanbesien K, Giralt S, Andersson B, Kleine HD, Seong D, Deisseroth AB, Andreeff M, Champlin R: Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma - Potential advantage of blood over marrow allografts. Blood 85:1659, 1995
3. Bensinger WI, Weaver CH, Appelbaum FR, Rowley S, Demirer T, Sanders J, Storb R, Buckner CD: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655, 1995
4. Brown RA, Adkins D, Goodnough M, Wehde D, Hendricks D, Ehlenbeck C, Laub L, DiPersio J: Allogeneic peripheral blood progenitor cell transplant does not appear to increase the risk of acute GVHD following HLA identical sibling transplant. Blood 86:393a, 1995 (abstr, suppl 1)
5. Russell JA, Brown C, Bowen T, Luider J, Ruether JD, Stewart D, Chaudhry A, Booth K, Jorgerson K, Coppes MJ, Turener AR, Larratt L, Desai S, Poon MC, Klassen J: Allogeneic blood cell transplants for haematological malignancy: Preliminary comparison of outcomes with bone marrow transplantation. Bone Marrow Transplant 17:703, 1996
6. Urbano-Ispizua A, Solano C, Brunet S, Hernandez F, Sanz G, Alegre A, Petit J, Besalduch J, Vivancos P, Diaz MA, Moraleda JM, Carreras E, Ojeda E, DeLaRubia J, Benet I, Domingo-Albos A, Garcia-Conde J, Rozman C: Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. Bone Marrow Transplant 18:35, 1996
7. Bacigalupo A, VanLint MT, Valbonesi M, Lercari G, Carlier P, Lamparelli T, Gualandi F, Occhini D, Bregante S, Valeriani A, Piaggio G, Pitto A, Benvenuto P, Figari O, DeStefano G, Caimo A, Sessarego M: Thiotepa cyclophosphamice followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood stem cells in adults with advanced leukemia. Blood 88:353, 1996
8. Bensinger WI, Clift R, Martin P, Appelbaum FR, Demirer T, Gooley T, Lilleby K, Rowley S, Sanders J, Storb R, Buckner CD: Allogeneic peripheral blood stem cell transplantation in patients with advanced hemotologic malignancies: A retrospective comparison with marrow transplantation. Blood 88:2794, 1996
9. Przepiorka D, Anderlini P, Ippoliti C, Khouri I, Fietz T, Thall P, Mehra R, Giralt S, Gajewski J, Deisseroth AB, Cleary K, Champlin R, VanBesien K, Andersson B: Allogeneic blood stem cell transplantation in advanced hematologic cancers. Bone Marrow Transplant 19:455, 1997
10. Ottinger HD, Beelen DW, Scheulen B, Schaeffer UW, Grosse-Wilde H: Improved immune reconstitution after allotransplantation of peripheral blood stem cells instead of bone marrow. Blood 88:2775, 1996
11. Storek J, Witherspoon RP, Maloney DG, Chauncey TR, Storb R: Improved reconstitution of CD4 T cells and B cells but worsened reconstitution of serum IgG levels after allogeneic transplantation of blood stem cells instead of marrow (letter). Blood 89:3891, 1997
12. Storek J, Witherspoon RP: Immunological reconstitution after hemopoietic stem cell transplantation, in Atkinson K (ed): Clinical Bone Marrow and Blood Stem Cell Transplantation: A Reference Textbook (ed 2). Cambridge, UK, Cambridge (in press)
13. Ferrara JLM, Deeg HJ, Burakoff SJ: Graft-vs.-Host Disease (ed 2). New York, NY, Marcel Dekker, 1997
14. Storb R, Doney KC, Thomas ED, Appelbaum F, Buckner CD, Clift RA, Deeg HJ, Goodell BW, Hackman R, Hansen JA, Sanders J, Sullivan K, Weiden PL, Witherspoon RP: Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. Blood 59:236, 1982
15. Niederwieser D, Pepe M, Storb R, Witherspoon R, Longton G, Sullivan K: Factors predicting chronic graft-versus-host disease and survival after marrow transplantation for aplastic anemia. Bone Marrow Transplant 4:151, 1989
16. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, Hackman R, Tsoi MS, Storb R, Thomas ED: Chronic graft-versus-host syndrome in man A long-term clinicopathologic study of 20 Seattle patients. Am J Med 69:204, 1980
17. Pepe MS, Mori M: Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 12:737, 1993
18. Pepe MS: Inference for events with dependent risks in multiple endpoint studies. J Am Stat Assoc 86:770, 1991
19. Sullivan KM: Graft-versus-host disease, in Forman SJ, Blume KG, Thomas ED (eds): Bone Marrow Transplantation. Boston, MA, Blackwell, 1994, p 339
20. Atkinson K, Horowitz MM, Gale RP, van Bekkum DW, Gluckman E, Good RA, Jacobsen N, Kolb HJ, Rimm AA, Ringden O, Rozman C, Sobocinski KA, Zwaan FE, Bortin MM: Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 75:2459, 1990
21. Bostrom L, Ringden O, Sundberg B, Ljungman P, Linde A, Nilsson B: Pretransplant herpes virus serology and chronic GHVD. Bone Marrow Transplant 4:457, 1989
22. Bostrom L, Ringden O, Jacobsen N, Zwaan F, Nilsson B: A European multicenter study of chronic GVHD. Transplantation 49:1100, 1990
23. Majolino I, Saglio G, Scime R, Serra A, Cavallaro AM, Fiandaca T, Vasta S, Pampinella M, Catania P, Indovina A, Marceno R, Santoro A: High incidence of chronic GVHD after primary allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies. Bone Marrow Transplant 17:555, 1996
24. Urbano-Ispizua A, Garcia-Conde S, Brunet S, Hernandez F, Sanz G, Alegre A, Petit J, Bargay J, Vivancos P, Solano C, Ojeda E, Domingo A, Rozman C: High incidence of chronic GVHD after allogeneic peripheral blood progenitor cell transplantation from matched related donors. Blood 88:617a, 1996 (abstr, suppl 1)
25. Korbling M, Mirza N, Thall P, Przepiorka D, Anderlini P, Huh Y, Fisher H, Fahmy H, Champlin R: 100 HLA-identical allogeneic blood stem transplantations: The M.D. Anderson Cancer Cancer experience. Bone Marrow Transplant 19:S72, 1997 (abstr, suppl 1)
26. Russell JA, Desai S, Herbut B, Brown C, Luider J, Ruether JD, Stewart D, Chaudhry A, Booth K, Jorgenson K, Coppes MJ, Turner AR, Larratt L, Poon MC, Klassen J: Partially mismatched blood cell transplants for high-risk hematologic malignancy. Bone Marrow Transplant 19:861, 1997
27. Pan L, Delmonte JJ, Jalonen CK, Ferrara JLM: Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental GVHD. Blood 86:4422, 1995
28. Pan L, Bressler S, Cooke KR, Krenger W, Karandikar M, Ferrara JLM: Long-term engraftment, GVHD, and immunologic reconstitution after experimental transplantation of allogeneic peripheral blood cells from G-CSF-treated donors. Biol Blood Marrow Transplant 2:126, 1996
29. Zeng D, Dejbakhsh-Jones S, Strober S: Granulocyte colony-stimulation factor reduces the capacity of blood mononuclear cells to induce graft-versus-host disease: Impact on blood progenitor cell transplantation. Blood 90:453, 1997
30. + cells derived from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells. Blood 89:1629, 1997
31. + suppressor cells in mobilized stem cell products. J Leukoc Biol 61:583, 1997
32. +) in the blood of normal donors. Blood 89:2586, 1997
33. Nawa Y, Teshima T, Sunami K, Hiramatsu Y, Yano T, Shinagawa K, Omoto E, Harada M: Responses of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells to alloantigen stimulation (letter). Blood 90:1716, 1997
34. Atkinson K, Farewell V, Storb R, Tsoi MS, Sullivan KM, Witherspoon RP, Fefer A, Clift R, Goodell B, Thomas ED: Analysis of late infections after human bone marrow transplantation: Role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. Blood 60:714, 1982
35. Sullivan KM, Mori M, Sanders J, Siadak M, Witherspoon RP, Anasetti C, Appelbaum FR, Bensinger W, Bowden R, Buckner CD: Late complications of allogeneic and autologous marrow transplantation. Bone Marrow Transplant 10:127, 1992 (suppl 1)
36. Ochs L, Shu XO, Miller J, Enright H, Wagner J, Filipovich A, Miller W, Weisdorf D: Late infections after allogeneic bone marrow transplantation: comparison of incidence in related and unrelated donor transplant recipients. Blood 86:3979, 1995
37. Storek J, Gooley T, Witherspoon RP, Sullivan KM, Storb R: Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts. Am J Hematol 54:131, 1997
38. Sullivan KM, Storek J, Kopecky KJ, Jocom JJ, Longton G, Flowers M, Siadak M, Nims J, Witherspoon RP, Anasetti C, Bowden R, Applebaum FR, Buckner CD, Deeg HJ, Hansen JA, McDonald GB, Sanders JE, Storb R: A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic GVHD following marrow transplantation: Clinical outcome and effect on subsequent immune recovery. Biol Blood Marrow Transplant 2:44, 1996
39. Sullivan KM, Weiden PL, Storb R, Witherspoon RP, Fefer A, Fisher L, Buckner CD, Anasetti C, Appelbaum FR, Badger C: Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia. Blood 73:1720, 1989
40. Slavin S, Akerstein A, Naparstek E, Or R, Weiss L: The graft-versus-leukemia phenomenon: Is GVL separable from GVHD? Bone Marrow Transplant 6:155, 1990
41. Glass B, Uharek L, Zeiss M, Dreger P, Loffler H, Steinmann J, Schmitz N: Allogeneic peripheral blood progenitor cell transplantation in a murine model: evidence for an improved graft-versus-leukemia effect. Blood 90:1694, 1997